Hôpital Neurologique,
Bron, 69677, France
Location status: Recruiting
NCT Number: NCT04189965
Few studies have focused on understanding the mechanisms underlying pain memory in humans. Thus, this project aims to investigate the link between pain memorisation and memorisation of the associated context by addressing the issue of pain conditioning. The study is composed of two successive parts: one pilot then one experimental. The goal is to understand pain memorisation processes by analysing the parallel between pain memorisation and memorisation of a traumatic event. By using immersive virtual reality, investigators aim to show that contextual pain conditioning is associated with : 1- a specific neural networks; 2- a reactivation of vegetative and behavioural reactions related to pain as well as electro-physiological markers when re-exposure to the specific pain-conditioning-context; 3- an implicit hypermnesia of the pain-associated context and a struggle to extinguish conditioning; 4- a favoured elaboration of false memories of the contextual pain. The emitted hypothesis suggests that a cortical and behavioural mnemonic trace is created during encoding of pain in association with its context, and that the latter can reactivate although the pain itself has disappeared. This implicit cortical mnemonic trace, evoked by the simple pain-associated context, could explain the notion of pain print persisting at long-term in patients suffering from chronic pain.
Interested in participating?
Request Info18 year–50 year
All sexes
Interventional
Not applicable
Bron, 69677, France
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The goal of this phase is the development of the experimental protocol in virtual reality. Virtual environment will be checked and auditive stimulation will be graduated.
This phase is the principal step of the study: during moving in virtual environment, electrical stimulation on one hand and auditive stimulation will be applied. EEG, ECG and skin conductance will be measured during conditioning phase and extinction phase (day 1, 30 minutes each phase). Behavioral measures will be done throughout the 3 sessions (day 1, day 2 and day 30)
This phase is the same of the Principal Experimental phase except for the EEG that will not be performed.
Time frame: day 1
The EEG will be done throughout the conditioning phase and the extinction phase (30 minutes each)conducted during the first session of the experiment (Day 1)
Time frame: day 1
The cutaneous response and electro-cardiographic activity will be done throughout the conditioning phase and the extinction phase (30 minutes each)conducted during the first session of the experiment (Day 1)
Time frame: day 2
This outcome is evaluated by combined tests:
Time frame: day 30
This outcome is evaluated by combined tests:
Time frame: day 2
Questionnaire will be conducted on environment (presence or absence of different objects) to assess false memories
Time frame: day 30
Questionnaire will be conducted on environment (presence or absence of different objects) to assess false memories
Time frame: Day 1
An Eye-tracking system will be included in the Virtual Reality glasses (used during conditioning and extinction) to assess eye-movement during exploration of the environment
Time frame: 30 minutes
The amount of time needed for vegetative reactions to go back to baseline will be assessed during the extinction phase
Contact information is provided by the study sponsor or research team.
Hospices Civils de Lyon
Other
Traumatic Long-term Memory of Pain - Pain Conditioning Study in Humans
Acronym: TRAUMADOL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07738718
Dental Anxiety, Neurologic Manifestations
Ar Rass, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT05563792
Agnosia, Chronic Pain
Indianapolis, Indiana, United States
View Trial DetailsNCT07226700
Agnosia, JOURNAVX
New York, United States
View Trial DetailsNCT02446262
Healthy Volunteers, Neurologic Manifestations
Bethesda, Maryland, United States
View Trial Details